A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

ABSTRACT:

Background

The opioid epidemic is a public health crisis. Medications for opioid use disorder (MOUD) include: 1) buprenorphine, 2) methadone, and 3) extended-release naltrexone (XR-NTX). Research should investigate patients' and providers' perspectives of MOUD since they can influence prescription, retention, and recovery.

Methods

This systematic review focused on patients' and providers' perceptions of MOUD. The review eligibility criteria included inclusion of the outcome of interest, in English, and involving persons ≥18 years. A PubMed database search yielded 1692 results; we included 152 articles in the final review.

Results

There were 63 articles about buprenorphine, 115 articles about methadone, and 16 about naltrexone. Misinformation and stigma associated with

SUBMITTER: Cioe K 

PROVIDER: S-EPMC7609980 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature